SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, June 04, 2025--Biocom California, the association representing the California life science industry, today announced the appointment of Thierry ...

Protein degradation company Plexium has laid off staff as part of a realignment to support the company’s pipeline, which is ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

In this week’s edition of The Prototype, we look at why you still can’t rely on chatbots, a new battery chemistry that could ...

The San Diego company is already in discussions related ... The asset, which Erasca picked up from Novartis for $20 million in 2022, would be the first targeted therapy in NRASm melanoma if ...

Delphia Therapeutics, Inc. (Delphia), a biopharmaceutical company pioneering a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene ...

Novartis has reached an agreement to take control ... The Swiss pharma group said in a statement that the takeover of the San Diego-based startup will bolster its position in gene therapies ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing ...

Timothy Kieffer, Ph.D., appointed Chief Scientific Officer Danny Villeneuve appointed Chief Commercial Officer Terrie Kellmeyer, Ph.D., appointed Senior Vice President, Regulatory Affairs Christian ...

Racial and ethnic differences in the severity, prognosis, and mortality of multiple sclerosis (MS) have been the focus of intensifying research over the last decade, and emerging evidence suggests ...

A “killer” movie franchise that got its start in San Diego is back. Thursday, the production crew for Attack of the Killer ...

One university graduate said America "is losing scientific talent because of this broad, systematic attack on science funding ...